Outcomes of proton therapy to infradiaphragmatic sites in pediatric patients with Hodgkin lymphoma.

Cecilia JiangMichele KimXiaoyan HanMonica CheliusTravis HooverLeslie KersunAnne F ReillyHarper HubbelingElizabeth CummingsGoldie KurtzChristine Hill-KayserJohn P PlastarasMichael J LaRiviere

Published in: Pediatric blood & cancer (2024)

PT is well-tolerated and leads to excellent oncologic and toxicity outcomes with long-term follow-up. PT confers dosimetric advantages when compared to photons.

Keyphrases

hodgkin lymphoma
oxidative stress
prostate cancer
skeletal muscle
weight loss
childhood cancer